Concentrix CORP 8-K filings
Current reports — the filing a company makes when something happens that shareholders need to know about before the next quarterly report.
NASDAQ
CNXC
Concentrix CORPConcentrix Corporation has updated its executive severance plan to align with market practices and provide enhanced benefits.
NASDAQ
CNXC
Concentrix CORPConcentrix Corporation announced its second quarter 2026 financial results, reporting revenue within guidance and a record-high $258 million in cash flow from operations.
NASDAQ
CNXC
Concentrix CORPBilge Ogut resigned from the Concentrix Board of Directors after GBL's ownership fell below the required threshold.
NASDAQ
CNXC
Concentrix CORPConcentrix Corporation's stockholders approved an amendment to its 2020 Stock Incentive Plan, increasing available shares by 3.7 million, alongside director elections and auditor ratification.
NASDAQ
CNXC
Concentrix CORPConcentrix Corporation reported mixed first-quarter 2026 financial results, with revenue increasing but GAAP operating income and net income declining year-over-year, while maintaining its full-year outlook.
NASDAQ
CNXC
Concentrix CORPConcentrix Corporation has amended its accounts receivable securitization facility, increasing available borrowings to $750 million and extending the termination date to March 20, 2028.
NASDAQ
CNXC
Concentrix CORPConcentrix Corporation successfully refinanced $600 million of its senior notes, securing a lower interest rate and extending maturity.
NASDAQ
CNXC
Concentrix CORPConcentrix Corporation announced the pricing of $600 million in new senior notes to refinance a portion of its existing 2026 debt, securing a lower interest rate and extended maturity.
NASDAQ
CNXC
Concentrix CORPConcentrix Corporation announced fourth quarter and fiscal year 2025 results, exceeding revenue guidance while reporting a significant non-cash goodwill impairment charge.
NASDAQ
CNXC
Concentrix CORPConcentrix Corporation reported third quarter 2025 financial results, surpassing revenue guidance and raising its full-year growth projections.
NASDAQ
CNXC
Concentrix CORPConcentrix Corporation reported strong second-quarter revenue exceeding expectations and raised its full-year growth outlook, driven by strategic investments in AI and anticipated accelerated client activity in the second half of fiscal 2025.
NASDAQ
CNXC
Concentrix CORPConcentrix Corporation disclosed that Olivier Duha has resigned from its Board of Directors effective June 3, 2025, citing personal reasons and no disagreement with the company.
NASDAQ
CNXC
Concentrix CORPConcentrix Corporation amends and restates its credit agreement, securing $3.3 billion in borrowing capacity and extending debt maturities.
NASDAQ
CNXC
Concentrix CORPConcentrix Corporation's stockholders approved an amendment to the company's charter, allowing stockholders owning at least 25% of common stock to call a special meeting, subject to certain conditions.
NASDAQ
CNXC
Concentrix CORPConcentrix Corporation reports strong first quarter results, exceeding revenue and profit guidance, and reiterates its full-year fiscal 2025 outlook.
NASDAQ
CNXC
Concentrix CORPConcentrix Corporation increased its accounts receivable securitization facility commitment to $700 million and extended the termination date to January 2027.
NASDAQ
CNXC
Concentrix CORPConcentrix Corporation announces its Q4 and fiscal year 2024 results, highlighting revenue growth, shareholder returns, and the introduction of 2025 guidance with expected revenue growth and margin expansion.
NASDAQ
CNXC
Concentrix CORPConcentrix Corporation's board of directors has amended the company's bylaws to change the supermajority vote requirement for amending bylaws to a simple majority.
NASDAQ
CNXC
Concentrix CORPConcentrix Corporation has selected Ernst & Young LLP as its new independent auditor for the fiscal year ending November 30, 2025, replacing KPMG LLP.
NASDAQ
CNXC
Concentrix CORPConcentrix Corporation's stockholders approved amendments to the 2020 Stock Incentive Plan, including an increase of 3,000,000 authorized shares and the removal of the evergreen provision.
NASDAQ
CNXC
Concentrix CORPConcentrix exceeded revenue guidance and met profit expectations in Q3 2024, while also launching its first commercial AI product, iX Hello.
NASDAQ
CNXC
Concentrix CORPConcentrix reported strong second-quarter results, exceeding revenue expectations and raising its full-year revenue guidance, driven by solid demand for its technology and service offerings.
NASDAQ
CNXC
Concentrix CORPConcentrix Corporation has amended its accounts receivable securitization facility, increasing the borrowing capacity to $600 million and extending the termination date to April 2026.
NASDAQ
CNXC
Concentrix CORPConcentrix announced its first quarter 2024 financial results, with revenue reaching the high end of its guidance range and a commitment to share repurchases.
NASDAQ
CNXC
Concentrix CORPConcentrix Corporation held its 2024 Annual Meeting of Stockholders, electing ten directors, ratifying KPMG LLP as its auditor, and approving executive compensation on an advisory basis.
NASDAQ
CNXC
Concentrix CORPConcentrix Corporation has released unaudited financial statements for its recently acquired Webhelp business, along with pro forma combined financials.
NASDAQ
CNXC
Concentrix CORP8-K: Concentrix Reports Strong Q4 and Full Year Fiscal 2023 Results, Integration with Webhelp Progressing
Concentrix Corporation announced its fiscal fourth quarter and full year 2023 results, showcasing significant revenue growth and progress in its integration with Webhelp.